Skip to main content


Recent announcements from AI startups Abridge and OpenEvidence at HLTH reveal that these companies, previously distinct in their approaches, are now directly competing to attract physician users.


Recent data presented at ESMO 2025 strengthens the evidence that novel blood tests can assist doctors in determining which cancer patients require additional therapy and which patients may avoid further treatment.


Two prominent institutions have joined forces to develop a new publication aimed at serving as an alternative to the CDC's renowned Morbidity and Mortality Weekly Report (MMWR). This collaboration seeks to provide fresh perspectives and enhance public health reporting.


Promising developments in breast cancer treatment have emerged as AstraZeneca and Gilead report positive results from their recent trials. These findings bring hope for new therapies targeting aggressive forms of the disease, potentially improving outcomes for patients.


At a significant oncology conference, Merck presented groundbreaking data on cancer drugs that could play a crucial role in shaping the company's future success.


Amgen is actively filling in the gaps and addressing ongoing questions related to its gastric cancer drug, aiming to clarify the drug's potential and development progress.


The Department of Justice reports that Kaiser Permanente systematically manipulated patients' medical records to portray them as more severely ill, thereby increasing their claimed Medicare revenue.


The FDA has announced the first nine recipients of priority review vouchers. These vouchers expedite the review process for drugs that address key national health priorities, aiming to bring important treatments to market faster.


Starting this January, California will begin selling affordable insulin pens directly to consumers. This groundbreaking initiative is the first by any state to bypass pharmaceutical companies' control and address the high cost of diabetes treatment.


Mass General Brigham has implemented an AI-powered application designed to alleviate the shortage of primary care physicians. The app assists by questioning patients, reviewing their medical records, and compiling relevant information to support healthcare providers. However, this technological adoption has received a range of responses, with some expressing concerns about its use.